Eye signs in patients with parkinsonism: do they predict the development of multiple system atrophy?
This Practice Point commentary discusses Anderson et al.'s study of oculomotor function in multiple system atrophy (MSA). After comparing their findings with those in other disorders, the authors ...
Shares of Alterity Therapeutics ATHE were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for ...
Promising new research shows Alterity’s novel brain imaging tool could play a key role in diagnosing and tracking Multiple System Atrophy. Quality peer-reviewed publication highlights use of ...
STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback